Exact Mass: 510.4185

Exact Mass Matches: 510.4185

Found 397 metabolites which its exact mass value is equals to given mass value 510.4185, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Gallamine Triethiodide

(2-{2,3-bis[2-(triethylazaniumyl)ethoxy]phenoxy}ethyl)triethylazanium

C30H60N3O3 (510.4634)


A synthetic nondepolarizing blocking drug. The actions of gallamine triethiodide are similar to those of tubocurarine, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. It should be used cautiously in patients at risk from increased heart rate but may be preferred for patients with bradycardia. (From AMA Drug Evaluations Annual, 1992, p198)

   

Nb-Lignoceroyltryptamine

N-[2-(1H-indol-3-yl)Ethyl]tetracosanimidate

C34H58N2O (510.4549)


Nb-Lignoceroyltryptamine is found in alcoholic beverages. Nb-Lignoceroyltryptamine is an alkaloid from seeds of Annona reticulata (custard apple) and Rollina mucosa (biriba). Alkaloid from seeds of Annona reticulata (custard apple) and Rollina mucosa (biriba). Nb-Lignoceroyltryptamine is found in alcoholic beverages and fruits.

   

Nervonyl carnitine

Nervonyl carnitine

C31H60NO4 (510.4522)


Nervonyl carnitine is an acylcarnitine. Numerous disorders have been described that lead to disturbances in energy production and in intermediary metabolism in the organism which are characterized by the production and excretion of unusual acylcarnitines. A mutation in the gene coding for carnitine-acylcarnitine translocase or the OCTN2 transporter aetiologically causes a carnitine deficiency that results in poor intestinal absorption of dietary L-carnitine, its impaired reabsorption by the kidney and, consequently, in increased urinary loss of L-carnitine. Determination of the qualitative pattern of acylcarnitines can be of diagnostic and therapeutic importance. The betaine structure of carnitine requires special analytical procedures for recording. The ionic nature of L-carnitine causes a high water solubility which decreases with increasing chain length of the ester group in the acylcarnitines. Therefore, the distribution of L-carnitine and acylcarnitines in various organs is defined by their function and their physico-chemical properties as well. High performance liquid chromatography (HPLC) permits screening for free and total carnitine, as well as complete quantitative acylcarnitine determination, including the long-chain acylcarnitine profile. (PMID: 17508264, Monatshefte fuer Chemie (2005), 136(8), 1279-1291., Int J Mass Spectrom. 1999;188:39-52.).

   

DG(14:0/14:1(9Z)/0:0)

(2S)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (9Z)-tetradec-9-enoate

C31H58O5 (510.4284)


DG(14:0/14:1(9Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(14:0/14:1(9Z)/0:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the myristoleic acid moiety is derived from milk fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position. DG(14:0/14:1(9Z)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/14:1(9Z)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(14:1(9Z)/14:0/0:0)

(2S)-3-hydroxy-2-(tetradecanoyloxy)propyl (9Z)-tetradec-9-enoate

C31H58O5 (510.4284)


DG(14:1(9Z)/14:0/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(14:1(9Z)/14:0/0:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of myristic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the myristic acid moiety is derived from nutmeg and butter. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

Propylene glycol mono- and diesters of fats and fatty acids

Propylene glycol mono- and diesters of fats and fatty acids

C32H62O4 (510.4648)


Propylene glycol mono- and diesters of fats and fatty acids is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") It is used as a food additive .

   

DG(14:0/0:0/14:1n5)

(2R)-2-Hydroxy-3-(tetradecanoyloxy)propyl (5Z)-tetradec-5-enoic acid

C31H58O5 (510.4284)


DG(14:0/0:0/14:1n5) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(14:0/0:0/14:1n5), in particular, consists of one chain of myristic acid at the C-1 position and one chain of myristoleic acid at the C-3 position. The myristic acid moiety is derived from nutmeg and butter, while the myristoleic acid moiety is derived from milk fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

FAHFA(16:0/9-O-16:0)

9-[(1-oxohexadecyl)oxy]-hexadecanoic acid

C32H62O4 (510.4648)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/9-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 9-hydroxyhexadecanoic acid. It is alternatively named 9-PAHPA since it is the 9-hydroxy isomer of the PAHPA (palmitic acid-hydroxypalmitic acid) family.

   

FAHFA(16:0/5-O-16:0)

5-[(1-oxohexadecyl)oxy]-hexadecanoic acid

C32H62O4 (510.4648)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/5-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 5-hydroxyhexadecanoic acid. It is alternatively named 5-PAHPA since it is the 5-hydroxy isomer of the PAHPA (palmitic acid-hydroxypalmitic acid) family.

   

FAHFA(16:0/7-O-16:0)

7-[(1-oxohexadecyl)oxy]-hexadecanoic acid

C32H62O4 (510.4648)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/7-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 7-hydroxyhexadecanoic acid. It is alternatively named 7-PAHPA since it is the 7-hydroxy isomer of the PAHPA (palmitic acid-hydroxypalmitic acid) family.

   

FAHFA(16:0/8-O-16:0)

8-[(1-oxohexadecyl)oxy]-hexadecanoic acid

C32H62O4 (510.4648)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/8-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 8-hydroxyhexadecanoic acid. It is alternatively named 8-PAHPA since it is the 8-hydroxy isomer of the PAHPA (palmitic acid-hydroxypalmitic acid) family.

   

FAHFA(16:0/10-O-16:0)

10-[(1-oxohexadecyl)oxy]-hexadecanoic acid

C32H62O4 (510.4648)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/10-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 10-hydroxyhexadecanoic acid. It is alternatively named 10-PAHPA since it is the 10-hydroxy isomer of the PAHPA (palmitic acid-hydroxypalmitic acid) family.

   

FAHFA(16:0/11-O-16:0)

11-[(1-oxohexadecyl)oxy]-hexadecanoic acid

C32H62O4 (510.4648)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/11-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 11-hydroxyhexadecanoic acid. It is alternatively named 11-PAHPA since it is the 11-hydroxy isomer of the PAHPA (palmitic acid-hydroxypalmitic acid) family.

   

FAHFA(16:0/12-O-16:0)

12-[(1-oxohexadecyl)oxy]-hexadecanoic acid

C32H62O4 (510.4648)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/12-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 12-hydroxyhexadecanoic acid. It is alternatively named 12-PAHPA since it is the 12-hydroxy isomer of the PAHPA (palmitic acid-hydroxypalmitic acid) family.

   

FAHFA(16:0/13-O-16:0)

13-[(1-oxohexadecyl)oxy]-hexadecanoic acid

C32H62O4 (510.4648)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/13-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 13-hydroxyhexadecanoic acid. It is alternatively named 13-PAHPA since it is the 13-hydroxy isomer of the PAHPA (palmitic acid-hydroxypalmitic acid) family.

   

FAHFA(16:0/6-O-16:0)

6-[(1-oxohexadecyl)oxy]-hexadecanoic acid

C32H62O4 (510.4648)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:0/6-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitic acid with the hydroxy group of 6-hydroxyhexadecanoic acid. It is alternatively named 6-PAHPA since it is the 6-hydroxy isomer of the PAHPA (palmitic acid-hydroxypalmitic acid) family.

   

Dehydroeburicoic acid monoacetate

(2R)-2-[(3S,5R,10S,13R,14R,17R)-3-acetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid

C33H50O4 (510.3709)


Dehydroeburicoic acid monoacetate is a natural product found in Wolfiporia cocos with data available. Dehydroeburicoic acid monoacetate (Compound 18) is a lanostane triterpenoid isolated from Wolfiporia cocos[1]. Dehydroeburicoic acid monoacetate (Compound 18) is a lanostane triterpenoid isolated from Wolfiporia cocos[1].

   

Ekeberin D4

Ekeberin D4

C30H54O6 (510.392)


   

Concentricol

Concentricol

C30H54O6 (510.392)


   
   
   

germanicol-3-pentanoate

germanicol-3-pentanoate

C35H58O2 (510.4437)


   

3-O-Isovaleryl-beta-amyrin|beta-amyrin 3-methylbutanoate|beta-amyrin-3-(3-methylbutanonate)|beta-Amyrin-isovalerat

3-O-Isovaleryl-beta-amyrin|beta-amyrin 3-methylbutanoate|beta-amyrin-3-(3-methylbutanonate)|beta-Amyrin-isovalerat

C35H58O2 (510.4437)


   

(3beta,6alpha,12beta,20S,24?鈥?-form-Dammarane-3,6,12,20,24,25-hexol

(3beta,6alpha,12beta,20S,24?鈥?-form-Dammarane-3,6,12,20,24,25-hexol

C30H54O6 (510.392)


   

(4aR)-10c-Isocaleryloxy-1t.4ar.6at.6bc.9.9.12ac-heptamethyl-2-methylen-(8atH.12btH.14acH.14btH)-docosahydro-picen|3-Methybutanoyl-20(30)-Taraxasten-3-ol|3beta-Isovaleryloxy-18alpha.19betaH-ursen-(20(30))|3beta-Isovaleryloxy-taraxasten-(20(30))|Isovaleriansaeure-[taraxasten-(20(30))-yl-(3beta)-ester]|O-Isovaleryl-taraxasterol|psi-taraxasteryl-3-(3-methyl-butanoate)|Taraxasten-(20(30))-yl-(3beta)-isovalerat

(4aR)-10c-Isocaleryloxy-1t.4ar.6at.6bc.9.9.12ac-heptamethyl-2-methylen-(8atH.12btH.14acH.14btH)-docosahydro-picen|3-Methybutanoyl-20(30)-Taraxasten-3-ol|3beta-Isovaleryloxy-18alpha.19betaH-ursen-(20(30))|3beta-Isovaleryloxy-taraxasten-(20(30))|Isovaleriansaeure-[taraxasten-(20(30))-yl-(3beta)-ester]|O-Isovaleryl-taraxasterol|psi-taraxasteryl-3-(3-methyl-butanoate)|Taraxasten-(20(30))-yl-(3beta)-isovalerat

C35H58O2 (510.4437)


   

(14R)-ent-Kaur-16-en-14-yl fenchyl malonate

(14R)-ent-Kaur-16-en-14-yl fenchyl malonate

C33H50O4 (510.3709)


   

(2beta,3beta,19alpha)-19-hydroxy-2,3-(isopropyledenedioxy)urs-13(18)-en-28-oic acid gamma-lactone|serrulatin A

(2beta,3beta,19alpha)-19-hydroxy-2,3-(isopropyledenedioxy)urs-13(18)-en-28-oic acid gamma-lactone|serrulatin A

C33H50O4 (510.3709)


   

dimethyl 14-methylnonacosanedioate

dimethyl 14-methylnonacosanedioate

C32H62O4 (510.4648)


   

Lupeol-isovalerat

Lupeol-isovalerat

C35H58O2 (510.4437)


   

cyclopodmenyl acetate

cyclopodmenyl acetate

C35H58O2 (510.4437)


   
   

glut-5-ene-3alpha-methylbutyrate

glut-5-ene-3alpha-methylbutyrate

C35H58O2 (510.4437)


   

2-[rel-(3R,3aR,6S,7S,9bR,)-6-(3-ethoxy-3-oxopropyl)-2,3,3a,4,6,7,8,9b-octahydro-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1H-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid|3,4-secolanosta-4(28),7,9(11),24(31)-tetraene-3,21-dioic acid-3-ethyl ester|poricoic acid CE

2-[rel-(3R,3aR,6S,7S,9bR,)-6-(3-ethoxy-3-oxopropyl)-2,3,3a,4,6,7,8,9b-octahydro-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1H-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid|3,4-secolanosta-4(28),7,9(11),24(31)-tetraene-3,21-dioic acid-3-ethyl ester|poricoic acid CE

C33H50O4 (510.3709)


   

Isobauerenol-isovalerat

Isobauerenol-isovalerat

C35H58O2 (510.4437)


   

(14R)-ent-Kaur-16-en-14-yl epi-bornyl malonate

(14R)-ent-Kaur-16-en-14-yl epi-bornyl malonate

C33H50O4 (510.3709)


   

ent-Kaur-16-en-15beta-yl epi-bornyl malonate

ent-Kaur-16-en-15beta-yl epi-bornyl malonate

C33H50O4 (510.3709)


   

isopimaryl 4beta<(3alpha-methyl-2beta-methoxycarbonyl)cyclopentyl>-2-pentenoate|isopimaryl 4beta[(3alpha-methyl-2beta-methoxycarbonyl)cyclopentyl]-2-pentenoate

isopimaryl 4beta<(3alpha-methyl-2beta-methoxycarbonyl)cyclopentyl>-2-pentenoate|isopimaryl 4beta[(3alpha-methyl-2beta-methoxycarbonyl)cyclopentyl]-2-pentenoate

C33H50O4 (510.3709)


   

Diabolic acid

15,16-dimethyltriacontanedioic acid

C32H62O4 (510.4648)


   

(23S)-23-ethyl-24-methyl-cycloart-24(241)-en-3beta-yl acetate|Ac-23-Ethyl-24-methylenecycloartan-3-ol

(23S)-23-ethyl-24-methyl-cycloart-24(241)-en-3beta-yl acetate|Ac-23-Ethyl-24-methylenecycloartan-3-ol

C35H58O2 (510.4437)


   

betulinic acid

betulinic acid

C33H50O4 (510.3709)


   
   

lygodipenoid B

lygodipenoid B

C35H58O2 (510.4437)


   

O-(3-Methylbutanoyl)-3beta-12-Ursen-3-ol

O-(3-Methylbutanoyl)-3beta-12-Ursen-3-ol

C35H58O2 (510.4437)


   

(2R)-2-[(3S,5R,10S,13R,14R,17R)-3-acetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid

(2R)-2-[(3S,5R,10S,13R,14R,17R)-3-acetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid

C33H50O4 (510.3709)


   
   

psi-taraxasteryl 3-methylbutanoate

psi-taraxasteryl 3-methylbutanoate

C35H58O2 (510.4437)


   

3-O-acetoacetyl lupeol

3-O-acetoacetyl lupeol

C34H54O3 (510.4073)


   
   

Estradiol palmitate

Estradiol palmitate

C34H54O3 (510.4073)


   

Dimethyl triacontanedioate

Dimethyl triacontanedioate

C32H62O4 (510.4648)


   
   

(7E)-(1R,2S,3R)-2-(benzyloxy)-19-nor-9,10-seco-5,7-cholestadiene-1,3,25-triol

2α-(benzyloxy)-1α,25-dihydroxy-19-norvitamin D3 / 2α-(benzyloxy)-1α,25-dihydroxy-19-norcholecalciferol

C33H50O4 (510.3709)


   

Diglyceride

1-Myristoleoyl-2-myristoyl-sn-glycerol

C31H58O5 (510.4284)


   

Propylene glycol, fatty acid esters

Propylene glycol mono- and diesters of fats and fatty acids

C32H62O4 (510.4648)


   

tetracosanoic acid tryptamide

N-[2-(1H-indol-3-yl)ethyl]tetracosanamide

C34H58N2O (510.4549)


   

DG(12:0/16:1(9Z)/0:0)[iso2]

1-dodecanoyl-2-(9Z-hexadecenoyl)-sn-glycerol

C31H58O5 (510.4284)


   

5-PAHPA

5-hexadecanoyloxy-hexadecanoic acid

C32H62O4 (510.4648)


   

7-PAHPA

7-hexadecanoyloxy-hexadecanoic acid

C32H62O4 (510.4648)


   

8-PAHPA

8-hexadecanoyloxy-hexadecanoic acid

C32H62O4 (510.4648)


   

9-PAHPA

9-hexadecanoyloxy-hexadecanoic acid

C32H62O4 (510.4648)


   

10-PAHPA

10-hexadecanoyloxy-hexadecanoic acid

C32H62O4 (510.4648)


   

11-PAHPA

11-hexadecanoyloxy-hexadecanoic acid

C32H62O4 (510.4648)


   

12-PAHPA

12-hexadecanoyloxy-hexadecanoic acid

C32H62O4 (510.4648)


   

13-PAHPA

13-hexadecanoyloxy-hexadecanoic acid

C32H62O4 (510.4648)


   

FAHFA 32:0;O

13-tetradecanoyloxy-octadecanoic acid

C32H62O4 (510.4648)


   

DG 28:1

1-dodecanoyl-2-(9Z-hexadecenoyl)-sn-glycerol

C31H58O5 (510.4284)


   

2alpha-(benzyloxy)-1alpha,25-dihydroxy-19-norvitamin D3

(7E)-(1R,2S,3R)-2-(benzyloxy)-19-nor-9,10-seco-5,7-cholestadiene-1,3,25-triol

C33H50O4 (510.3709)


   

beta-Apo-2-carotenol

3,4-Didehydro-2-apo-beta,psi-caroten-2-ol

C37H50O (510.3861)


   

Ditridecyl adipate

Ditridecyl adipate

C32H62O4 (510.4648)


   

Octaethylene glycol monodecyl ether

Octaethylene glycol monodecyl ether

C26H54O9 (510.3768)


   

CATANAC SP ANTISTATIC AGENT

CATANAC SP ANTISTATIC AGENT

C25H55N2O6P (510.3798)


   

HYDROXYSTEARAMIDOPROPYL TRIMONIUM METHOSULFATE

HYDROXYSTEARAMIDOPROPYL TRIMONIUM METHOSULFATE

C25H54N2O6S (510.3702)


   

bis(11-methyldodecyl) hexanedioate

bis(11-methyldodecyl) hexanedioate

C32H62O4 (510.4648)


   

dotriacontanedioic acid

dotriacontanedioic acid

C32H62O4 (510.4648)


   

cholesteryl furfuryl carbonate

cholesteryl furfuryl carbonate

C33H50O4 (510.3709)


   

Flaxedil

Flaxedil

C30H60N3O3+3 (510.4634)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

2-Hexadecanoyloxyhexadecanoic acid

2-Hexadecanoyloxyhexadecanoic acid

C32H62O4 (510.4648)


   
   

9-Myristoyloxystearic acid

9-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

10-Myristoyloxystearic acid

10-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

12-Myristoyloxystearic acid

12-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

13-Myristoyloxystearic acid

13-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

[(2R)-3-carboxy-2-[(Z)-tetracos-15-enoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(Z)-tetracos-15-enoyl]oxypropyl]-trimethylazanium

C31H60NO4+ (510.4522)


   

[3-carboxy-2-[(E)-tetracos-15-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tetracos-15-enoyl]oxypropyl]-trimethylazanium

C31H60NO4+ (510.4522)


   

2-O-ethyl-PAF C-16

2-O-ethyl-PAF C-16

C26H57NO6P+ (510.3923)


   

1-Decanoyl-2-oleoylglycerol

1-Decanoyl-2-oleoylglycerol

C31H58O5 (510.4284)


A 1,2-diglyceride in which the acyl groups at positions 1 and 2 are specified as decanoyl and oleoyl respectively.

   

[3-carboxy-2-[(E)-tetracos-11-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tetracos-11-enoyl]oxypropyl]-trimethylazanium

C31H60NO4+ (510.4522)


   

N,N,N-Trimethyl-2-[[[(R)-3-(hexadecyloxy)-2-ethoxypropoxy]oxylato(oxo)phosphoranyl]oxy]ethane-1-aminium

N,N,N-Trimethyl-2-[[[(R)-3-(hexadecyloxy)-2-ethoxypropoxy]oxylato(oxo)phosphoranyl]oxy]ethane-1-aminium

C26H57NO6P+ (510.3923)


   

1-Capryl-2-oleoyl-sn-glycerol

1-Capryl-2-oleoyl-sn-glycerol

C31H58O5 (510.4284)


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as capryl (decanoyl) and oleoyl (9Z-octadecenoyl) respectively.

   

1-Oleoyl-2-decanoyl-sn-glycerol

1-Oleoyl-2-decanoyl-sn-glycerol

C31H58O5 (510.4284)


A 1,2-diacyl-sn-glycerol where oleoyl and decanoyl are the 1- and 2-acyl groups, respectively.

   

(3-decanoyloxy-2-hydroxypropyl) (Z)-octadec-9-enoate

(3-decanoyloxy-2-hydroxypropyl) (Z)-octadec-9-enoate

C31H58O5 (510.4284)


   

2-[Hydroxy-(2-hydroxy-3-octadecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(2-hydroxy-3-octadecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C26H57NO6P+ (510.3923)


   

NAOrn 11:0/13:1

NAOrn 11:0/13:1

C29H54N2O5 (510.4033)


   

NAOrn 13:1/11:0

NAOrn 13:1/11:0

C29H54N2O5 (510.4033)


   

NAOrn 10:0/14:1

NAOrn 10:0/14:1

C29H54N2O5 (510.4033)


   

NAOrn 14:1/10:0

NAOrn 14:1/10:0

C29H54N2O5 (510.4033)


   

[1-hydroxy-3-[(Z)-icos-11-enoxy]propan-2-yl] nonanoate

[1-hydroxy-3-[(Z)-icos-11-enoxy]propan-2-yl] nonanoate

C32H62O4 (510.4648)


   

[1-[(Z)-hexacos-15-enoxy]-3-hydroxypropan-2-yl] propanoate

[1-[(Z)-hexacos-15-enoxy]-3-hydroxypropan-2-yl] propanoate

C32H62O4 (510.4648)


   

[1-hydroxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] pentanoate

[1-hydroxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] pentanoate

C32H62O4 (510.4648)


   

[1-[(Z)-docos-13-enoxy]-3-hydroxypropan-2-yl] heptanoate

[1-[(Z)-docos-13-enoxy]-3-hydroxypropan-2-yl] heptanoate

C32H62O4 (510.4648)


   

(1-hydroxy-3-octoxypropan-2-yl) (Z)-henicos-11-enoate

(1-hydroxy-3-octoxypropan-2-yl) (Z)-henicos-11-enoate

C32H62O4 (510.4648)


   

[1-[(Z)-henicos-11-enoxy]-3-hydroxypropan-2-yl] octanoate

[1-[(Z)-henicos-11-enoxy]-3-hydroxypropan-2-yl] octanoate

C32H62O4 (510.4648)


   

(1-hydroxy-3-nonoxypropan-2-yl) (Z)-icos-11-enoate

(1-hydroxy-3-nonoxypropan-2-yl) (Z)-icos-11-enoate

C32H62O4 (510.4648)


   

(1-decoxy-3-hydroxypropan-2-yl) (Z)-nonadec-9-enoate

(1-decoxy-3-hydroxypropan-2-yl) (Z)-nonadec-9-enoate

C32H62O4 (510.4648)


   

[1-hydroxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] decanoate

[1-hydroxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] decanoate

C32H62O4 (510.4648)


   

(1-hydroxy-3-tetradecoxypropan-2-yl) (Z)-pentadec-9-enoate

(1-hydroxy-3-tetradecoxypropan-2-yl) (Z)-pentadec-9-enoate

C32H62O4 (510.4648)


   

(1-hexadecoxy-3-hydroxypropan-2-yl) (Z)-tridec-9-enoate

(1-hexadecoxy-3-hydroxypropan-2-yl) (Z)-tridec-9-enoate

C32H62O4 (510.4648)


   

[1-hydroxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] undecanoate

[1-hydroxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] undecanoate

C32H62O4 (510.4648)


   

(1-hydroxy-3-tridecoxypropan-2-yl) (Z)-hexadec-9-enoate

(1-hydroxy-3-tridecoxypropan-2-yl) (Z)-hexadec-9-enoate

C32H62O4 (510.4648)


   

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] tridecanoate

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] tridecanoate

C32H62O4 (510.4648)


   

(1-hydroxy-3-pentadecoxypropan-2-yl) (Z)-tetradec-9-enoate

(1-hydroxy-3-pentadecoxypropan-2-yl) (Z)-tetradec-9-enoate

C32H62O4 (510.4648)


   

[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] dodecanoate

[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] dodecanoate

C32H62O4 (510.4648)


   

(1-dodecoxy-3-hydroxypropan-2-yl) (Z)-heptadec-9-enoate

(1-dodecoxy-3-hydroxypropan-2-yl) (Z)-heptadec-9-enoate

C32H62O4 (510.4648)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] hexadecanoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] hexadecanoate

C32H62O4 (510.4648)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] pentadecanoate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] pentadecanoate

C32H62O4 (510.4648)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] tetradecanoate

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] tetradecanoate

C32H62O4 (510.4648)


   

(1-hydroxy-3-undecoxypropan-2-yl) (Z)-octadec-9-enoate

(1-hydroxy-3-undecoxypropan-2-yl) (Z)-octadec-9-enoate

C32H62O4 (510.4648)


   
   
   
   
   

Pentadecanoic acid (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)-2,4,6,8-nonatetrenyl ester

Pentadecanoic acid (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)-2,4,6,8-nonatetrenyl ester

C35H58O2 (510.4437)


   

Fahfa 5:0/27:0

Fahfa 5:0/27:0

C32H62O4 (510.4648)


   

Fahfa 8:0/24:0

Fahfa 8:0/24:0

C32H62O4 (510.4648)


   

Fahfa 25:0/7:0

Fahfa 25:0/7:0

C32H62O4 (510.4648)


   

Fahfa 7:0/25:0

Fahfa 7:0/25:0

C32H62O4 (510.4648)


   

Fahfa 26:0/6:0

Fahfa 26:0/6:0

C32H62O4 (510.4648)


   

Fahfa 23:0/9:0

Fahfa 23:0/9:0

C32H62O4 (510.4648)


   

Fahfa 27:0/5:0

Fahfa 27:0/5:0

C32H62O4 (510.4648)


   

Fahfa 24:0/8:0

Fahfa 24:0/8:0

C32H62O4 (510.4648)


   

Fahfa 9:0/23:0

Fahfa 9:0/23:0

C32H62O4 (510.4648)


   

Fahfa 6:0/26:0

Fahfa 6:0/26:0

C32H62O4 (510.4648)


   

Fahfa 13:0/19:0

Fahfa 13:0/19:0

C32H62O4 (510.4648)


   

Fahfa 19:0/13:0

Fahfa 19:0/13:0

C32H62O4 (510.4648)


   

Fahfa 11:0/21:0

Fahfa 11:0/21:0

C32H62O4 (510.4648)


   

Fahfa 20:0/12:0

Fahfa 20:0/12:0

C32H62O4 (510.4648)


   

Fahfa 10:0/22:0

Fahfa 10:0/22:0

C32H62O4 (510.4648)


   

Fahfa 22:0/10:0

Fahfa 22:0/10:0

C32H62O4 (510.4648)


   

Fahfa 12:0/20:0

Fahfa 12:0/20:0

C32H62O4 (510.4648)


   

Fahfa 21:0/11:0

Fahfa 21:0/11:0

C32H62O4 (510.4648)


   

(1-hydroxy-3-nonanoyloxypropan-2-yl) (Z)-nonadec-9-enoate

(1-hydroxy-3-nonanoyloxypropan-2-yl) (Z)-nonadec-9-enoate

C31H58O5 (510.4284)


   

(1-hydroxy-3-undecanoyloxypropan-2-yl) (Z)-heptadec-9-enoate

(1-hydroxy-3-undecanoyloxypropan-2-yl) (Z)-heptadec-9-enoate

C31H58O5 (510.4284)


   

[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropyl] pentadecanoate

[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropyl] pentadecanoate

C31H58O5 (510.4284)


   

(1-dodecanoyloxy-3-hydroxypropan-2-yl) (Z)-hexadec-9-enoate

(1-dodecanoyloxy-3-hydroxypropan-2-yl) (Z)-hexadec-9-enoate

C31H58O5 (510.4284)


   

[3-hydroxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] tetradecanoate

[3-hydroxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] tetradecanoate

C31H58O5 (510.4284)


   

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (Z)-pentadec-9-enoate

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (Z)-pentadec-9-enoate

C31H58O5 (510.4284)


   

[(2S)-3-hydroxy-2-tridecanoyloxypropyl] (E)-pentadec-9-enoate

[(2S)-3-hydroxy-2-tridecanoyloxypropyl] (E)-pentadec-9-enoate

C31H58O5 (510.4284)


   

(1-heptanoyloxy-3-hydroxypropan-2-yl) (Z)-henicos-11-enoate

(1-heptanoyloxy-3-hydroxypropan-2-yl) (Z)-henicos-11-enoate

C31H58O5 (510.4284)


   

(1-acetyloxy-3-hydroxypropan-2-yl) (Z)-hexacos-15-enoate

(1-acetyloxy-3-hydroxypropan-2-yl) (Z)-hexacos-15-enoate

C31H58O5 (510.4284)


   

(1-butanoyloxy-3-hydroxypropan-2-yl) (Z)-tetracos-13-enoate

(1-butanoyloxy-3-hydroxypropan-2-yl) (Z)-tetracos-13-enoate

C31H58O5 (510.4284)


   

(1-hydroxy-3-octanoyloxypropan-2-yl) (Z)-icos-11-enoate

(1-hydroxy-3-octanoyloxypropan-2-yl) (Z)-icos-11-enoate

C31H58O5 (510.4284)


   

(1-hexanoyloxy-3-hydroxypropan-2-yl) (Z)-docos-13-enoate

(1-hexanoyloxy-3-hydroxypropan-2-yl) (Z)-docos-13-enoate

C31H58O5 (510.4284)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

2-Myristoyloxystearic acid

2-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

3-Myristoyloxystearic acid

3-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

4-Myristoyloxystearic acid

4-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

5-Myristoyloxystearic acid

5-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

6-Myristoyloxystearic acid

6-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

7-Myristoyloxystearic acid

7-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

8-Myristoyloxystearic acid

8-Myristoyloxystearic acid

C32H62O4 (510.4648)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

11-Myristoyloxystearic acid

11-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

14-Myristoyloxystearic acid

14-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

15-Myristoyloxystearic acid

15-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

16-Myristoyloxystearic acid

16-Myristoyloxystearic acid

C32H62O4 (510.4648)


   

17-Myristoyloxystearic acid

17-Myristoyloxystearic acid

C32H62O4 (510.4648)


   
   
   
   
   
   
   

2-[Hydroxy-(3-hydroxy-2-octadecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(3-hydroxy-2-octadecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C26H57NO6P+ (510.3923)


   

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (E)-heptadec-9-enoate

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (E)-heptadec-9-enoate

C31H58O5 (510.4284)


   

[(2S)-3-hydroxy-2-undecanoyloxypropyl] (E)-heptadec-9-enoate

[(2S)-3-hydroxy-2-undecanoyloxypropyl] (E)-heptadec-9-enoate

C31H58O5 (510.4284)


   

[(2S)-2-dodecanoyloxy-3-hydroxypropyl] (E)-hexadec-9-enoate

[(2S)-2-dodecanoyloxy-3-hydroxypropyl] (E)-hexadec-9-enoate

C31H58O5 (510.4284)


   

[(2S)-1-hydroxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] tetradecanoate

[(2S)-1-hydroxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] tetradecanoate

C31H58O5 (510.4284)


   

[1-carboxy-3-[2-hydroxy-3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-hydroxy-3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]propyl]-trimethylazanium

C29H52NO6+ (510.3794)


   

[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (E)-octadec-11-enoate

[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (E)-octadec-11-enoate

C31H58O5 (510.4284)


   

[(2S)-1-dodecanoyloxy-3-hydroxypropan-2-yl] (E)-hexadec-9-enoate

[(2S)-1-dodecanoyloxy-3-hydroxypropan-2-yl] (E)-hexadec-9-enoate

C31H58O5 (510.4284)


   

[(2S)-3-hydroxy-2-[(E)-tetradec-9-enoyl]oxypropyl] tetradecanoate

[(2S)-3-hydroxy-2-[(E)-tetradec-9-enoyl]oxypropyl] tetradecanoate

C31H58O5 (510.4284)


   

[(2S)-1-hydroxy-3-tridecanoyloxypropan-2-yl] (E)-pentadec-9-enoate

[(2S)-1-hydroxy-3-tridecanoyloxypropan-2-yl] (E)-pentadec-9-enoate

C31H58O5 (510.4284)


   

[(2S)-2-decanoyloxy-3-hydroxypropyl] (E)-octadec-11-enoate

[(2S)-2-decanoyloxy-3-hydroxypropyl] (E)-octadec-11-enoate

C31H58O5 (510.4284)


   

Diacylglycerol(14:0/14:1)

Diacylglycerol(14:0/14:1)

C31H58O5 (510.4284)


   

13-hexadecanoyloxy-hexadecanoic acid

13-hexadecanoyloxy-hexadecanoic acid

C32H62O4 (510.4648)


   

diacylglycerol 28:1

diacylglycerol 28:1

C31H58O5 (510.4284)


A diglyceride in which the two acyl groups contain a total of 28 carbons and 1 double bond.

   

TG(27:1)

TG(11:0_6:0_10:1)

C30H54O6 (510.392)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

OAHFA(32:0)

OAHFA(16:0_16:0)

C32H62O4 (510.4648)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MG(29:1)

MG(29:1)

C32H62O4 (510.4648)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hydroxytetratriacontaheptaenoic acid

Hydroxytetratriacontaheptaenoic acid

C34H54O3 (510.4073)


   
   
   
   

NA-Tryptamine 24:0

NA-Tryptamine 24:0

C34H58N2O (510.4549)


   
   

FAHFA 10:0/2O-22:0

FAHFA 10:0/2O-22:0

C32H62O4 (510.4648)


   

FAHFA 10:0/O-22:0

FAHFA 10:0/O-22:0

C32H62O4 (510.4648)


   

FAHFA 10:0/O-23:7

FAHFA 10:0/O-23:7

C33H50O4 (510.3709)


   

FAHFA 10:1/O-23:6

FAHFA 10:1/O-23:6

C33H50O4 (510.3709)


   

FAHFA 10:2/O-23:5

FAHFA 10:2/O-23:5

C33H50O4 (510.3709)


   

FAHFA 10:3/O-23:4

FAHFA 10:3/O-23:4

C33H50O4 (510.3709)


   

FAHFA 11:0/O-21:0

FAHFA 11:0/O-21:0

C32H62O4 (510.4648)


   

FAHFA 11:0/O-22:7

FAHFA 11:0/O-22:7

C33H50O4 (510.3709)


   

FAHFA 11:1/O-22:6

FAHFA 11:1/O-22:6

C33H50O4 (510.3709)


   

FAHFA 11:2/O-22:5

FAHFA 11:2/O-22:5

C33H50O4 (510.3709)


   

FAHFA 11:3/O-22:4

FAHFA 11:3/O-22:4

C33H50O4 (510.3709)


   

FAHFA 12:0/O-20:0

FAHFA 12:0/O-20:0

C32H62O4 (510.4648)


   

FAHFA 12:0/O-21:7

FAHFA 12:0/O-21:7

C33H50O4 (510.3709)


   

FAHFA 12:1/O-21:6

FAHFA 12:1/O-21:6

C33H50O4 (510.3709)


   

FAHFA 12:2/O-21:5

FAHFA 12:2/O-21:5

C33H50O4 (510.3709)


   

FAHFA 12:3/O-21:4

FAHFA 12:3/O-21:4

C33H50O4 (510.3709)


   

FAHFA 12:4/O-21:3

FAHFA 12:4/O-21:3

C33H50O4 (510.3709)


   

FAHFA 13:0/O-19:0

FAHFA 13:0/O-19:0

C32H62O4 (510.4648)


   

FAHFA 13:1/O-20:6

FAHFA 13:1/O-20:6

C33H50O4 (510.3709)


   

FAHFA 13:2/O-20:5

FAHFA 13:2/O-20:5

C33H50O4 (510.3709)


   

FAHFA 13:3/O-20:4

FAHFA 13:3/O-20:4

C33H50O4 (510.3709)


   

FAHFA 13:4/O-20:3

FAHFA 13:4/O-20:3

C33H50O4 (510.3709)


   

FAHFA 14:0/12O-18:0

FAHFA 14:0/12O-18:0

C32H62O4 (510.4648)


   

FAHFA 14:0/O-18:0

FAHFA 14:0/O-18:0

C32H62O4 (510.4648)


   

FAHFA 14:1/O-19:6

FAHFA 14:1/O-19:6

C33H50O4 (510.3709)


   

FAHFA 14:2/O-19:5

FAHFA 14:2/O-19:5

C33H50O4 (510.3709)


   

FAHFA 14:3/O-19:4

FAHFA 14:3/O-19:4

C33H50O4 (510.3709)


   

FAHFA 14:4/O-19:3

FAHFA 14:4/O-19:3

C33H50O4 (510.3709)


   

FAHFA 15:0/O-17:0

FAHFA 15:0/O-17:0

C32H62O4 (510.4648)


   

FAHFA 15:1/O-18:6

FAHFA 15:1/O-18:6

C33H50O4 (510.3709)


   

FAHFA 15:2/O-18:5

FAHFA 15:2/O-18:5

C33H50O4 (510.3709)


   

FAHFA 15:3/O-18:4

FAHFA 15:3/O-18:4

C33H50O4 (510.3709)


   

FAHFA 15:4/O-18:3

FAHFA 15:4/O-18:3

C33H50O4 (510.3709)


   

FAHFA 15:5/O-18:2

FAHFA 15:5/O-18:2

C33H50O4 (510.3709)


   

FAHFA 16:0/3O-16:0

FAHFA 16:0/3O-16:0

C32H62O4 (510.4648)


   

FAHFA 16:0/O-16:0

FAHFA 16:0/O-16:0

C32H62O4 (510.4648)


   

FAHFA 16:2/O-17:5

FAHFA 16:2/O-17:5

C33H50O4 (510.3709)


   

FAHFA 16:3/O-17:4

FAHFA 16:3/O-17:4

C33H50O4 (510.3709)


   

FAHFA 16:4/O-17:3

FAHFA 16:4/O-17:3

C33H50O4 (510.3709)


   

FAHFA 16:5/O-17:2

FAHFA 16:5/O-17:2

C33H50O4 (510.3709)


   

FAHFA 17:0/15O-15:0

FAHFA 17:0/15O-15:0

C32H62O4 (510.4648)


   

FAHFA 17:0/O-15:0

FAHFA 17:0/O-15:0

C32H62O4 (510.4648)


   

FAHFA 17:2/O-16:5

FAHFA 17:2/O-16:5

C33H50O4 (510.3709)


   

FAHFA 17:3/O-16:4

FAHFA 17:3/O-16:4

C33H50O4 (510.3709)


   

FAHFA 17:4/O-16:3

FAHFA 17:4/O-16:3

C33H50O4 (510.3709)


   

FAHFA 17:5/O-16:2

FAHFA 17:5/O-16:2

C33H50O4 (510.3709)


   

FAHFA 18:0/2O-14:0

FAHFA 18:0/2O-14:0

C32H62O4 (510.4648)


   

FAHFA 18:0/O-14:0

FAHFA 18:0/O-14:0

C32H62O4 (510.4648)


   

FAHFA 18:2/O-15:5

FAHFA 18:2/O-15:5

C33H50O4 (510.3709)


   

FAHFA 18:3/O-15:4

FAHFA 18:3/O-15:4

C33H50O4 (510.3709)


   

FAHFA 18:4/O-15:3

FAHFA 18:4/O-15:3

C33H50O4 (510.3709)


   

FAHFA 18:5/O-15:2

FAHFA 18:5/O-15:2

C33H50O4 (510.3709)


   

FAHFA 18:6/O-15:1

FAHFA 18:6/O-15:1

C33H50O4 (510.3709)


   

FAHFA 19:0/O-13:0

FAHFA 19:0/O-13:0

C32H62O4 (510.4648)


   

FAHFA 19:3/O-14:4

FAHFA 19:3/O-14:4

C33H50O4 (510.3709)


   

FAHFA 19:4/O-14:3

FAHFA 19:4/O-14:3

C33H50O4 (510.3709)


   

FAHFA 19:5/O-14:2

FAHFA 19:5/O-14:2

C33H50O4 (510.3709)


   

FAHFA 19:6/O-14:1

FAHFA 19:6/O-14:1

C33H50O4 (510.3709)


   

FAHFA 20:0/3O-12:0

FAHFA 20:0/3O-12:0

C32H62O4 (510.4648)


   

FAHFA 20:0/O-12:0

FAHFA 20:0/O-12:0

C32H62O4 (510.4648)


   

FAHFA 20:3/O-13:4

FAHFA 20:3/O-13:4

C33H50O4 (510.3709)


   

FAHFA 20:4/O-13:3

FAHFA 20:4/O-13:3

C33H50O4 (510.3709)


   

FAHFA 20:5/O-13:2

FAHFA 20:5/O-13:2

C33H50O4 (510.3709)


   

FAHFA 20:6/O-13:1

FAHFA 20:6/O-13:1

C33H50O4 (510.3709)


   

FAHFA 21:0/O-11:0

FAHFA 21:0/O-11:0

C32H62O4 (510.4648)


   

FAHFA 21:3/O-12:4

FAHFA 21:3/O-12:4

C33H50O4 (510.3709)


   

FAHFA 21:4/O-12:3

FAHFA 21:4/O-12:3

C33H50O4 (510.3709)


   

FAHFA 21:5/O-12:2

FAHFA 21:5/O-12:2

C33H50O4 (510.3709)


   

FAHFA 21:6/O-12:1

FAHFA 21:6/O-12:1

C33H50O4 (510.3709)


   

FAHFA 21:7/O-12:0

FAHFA 21:7/O-12:0

C33H50O4 (510.3709)


   

FAHFA 22:0/O-10:0

FAHFA 22:0/O-10:0

C32H62O4 (510.4648)


   

FAHFA 22:4/O-11:3

FAHFA 22:4/O-11:3

C33H50O4 (510.3709)


   

FAHFA 22:5/O-11:2

FAHFA 22:5/O-11:2

C33H50O4 (510.3709)


   

FAHFA 22:6/O-11:1

FAHFA 22:6/O-11:1

C33H50O4 (510.3709)


   

FAHFA 22:7/O-11:0

FAHFA 22:7/O-11:0

C33H50O4 (510.3709)


   

FAHFA 23:0/O-9:0

FAHFA 23:0/O-9:0

C32H62O4 (510.4648)


   

FAHFA 23:4/O-10:3

FAHFA 23:4/O-10:3

C33H50O4 (510.3709)


   

FAHFA 23:5/O-10:2

FAHFA 23:5/O-10:2

C33H50O4 (510.3709)


   

FAHFA 23:6/O-10:1

FAHFA 23:6/O-10:1

C33H50O4 (510.3709)


   

FAHFA 23:7/O-10:0

FAHFA 23:7/O-10:0

C33H50O4 (510.3709)


   

FAHFA 24:0/O-8:0

FAHFA 24:0/O-8:0

C32H62O4 (510.4648)


   

FAHFA 24:4/O-9:3

FAHFA 24:4/O-9:3

C33H50O4 (510.3709)


   

FAHFA 24:5/O-9:2

FAHFA 24:5/O-9:2

C33H50O4 (510.3709)


   

FAHFA 24:6/O-9:1

FAHFA 24:6/O-9:1

C33H50O4 (510.3709)


   

FAHFA 24:7/O-9:0

FAHFA 24:7/O-9:0

C33H50O4 (510.3709)


   

FAHFA 25:5/O-8:2

FAHFA 25:5/O-8:2

C33H50O4 (510.3709)


   

FAHFA 25:6/O-8:1

FAHFA 25:6/O-8:1

C33H50O4 (510.3709)


   

FAHFA 25:7/O-8:0

FAHFA 25:7/O-8:0

C33H50O4 (510.3709)


   

FAHFA 33:7;O

FAHFA 33:7;O

C33H50O4 (510.3709)


   

FAHFA 8:0/O-24:0

FAHFA 8:0/O-24:0

C32H62O4 (510.4648)


   

FAHFA 8:0/O-25:7

FAHFA 8:0/O-25:7

C33H50O4 (510.3709)


   

FAHFA 8:1/O-25:6

FAHFA 8:1/O-25:6

C33H50O4 (510.3709)


   

FAHFA 8:2/O-25:5

FAHFA 8:2/O-25:5

C33H50O4 (510.3709)


   

FAHFA 9:0/O-23:0

FAHFA 9:0/O-23:0

C32H62O4 (510.4648)


   

FAHFA 9:0/O-24:7

FAHFA 9:0/O-24:7

C33H50O4 (510.3709)


   

FAHFA 9:1/O-24:6

FAHFA 9:1/O-24:6

C33H50O4 (510.3709)


   

FAHFA 9:2/O-24:5

FAHFA 9:2/O-24:5

C33H50O4 (510.3709)


   

FAHFA 9:3/O-24:4

FAHFA 9:3/O-24:4

C33H50O4 (510.3709)


   

DG 10:0_18:1

DG 10:0_18:1

C31H58O5 (510.4284)


   

DG 11:0_17:1

DG 11:0_17:1

C31H58O5 (510.4284)


   

DG 12:0_16:1

DG 12:0_16:1

C31H58O5 (510.4284)


   

DG 12:1_16:0

DG 12:1_16:0

C31H58O5 (510.4284)


   

DG 13:0_15:1

DG 13:0_15:1

C31H58O5 (510.4284)


   

DG 14:0_14:1

DG 14:0_14:1

C31H58O5 (510.4284)


   

DG O-14:0_15:1

DG O-14:0_15:1

C32H62O4 (510.4648)


   

DG O-16:1_13:0

DG O-16:1_13:0

C32H62O4 (510.4648)


   

DG O-18:1_11:0

DG O-18:1_11:0

C32H62O4 (510.4648)


   
   

DG P-14:0_15:0

DG P-14:0_15:0

C32H62O4 (510.4648)


   

DG P-16:0_13:0

DG P-16:0_13:0

C32H62O4 (510.4648)


   

DG P-18:0_11:0

DG P-18:0_11:0

C32H62O4 (510.4648)


   
   

Vitamin D3 octanoate

Vitamin D3 octanoate

C35H58O2 (510.4437)


Vitamin D3 octanoate is an octanoate ester of vitamin D3[1]. Vitamin D3 (Cholecalciferol; HY-15398) is a naturally occuring form of vitamin D. Vitamin D3 induces cell differentiation and prevents proliferation of cancer cells[2].

   

2,6,10,15,19,23-hexamethyltetracosa-2,10,14,22-tetraene-1,6,7,18,19,24-hexol

2,6,10,15,19,23-hexamethyltetracosa-2,10,14,22-tetraene-1,6,7,18,19,24-hexol

C30H54O6 (510.392)


   

(1s,2s,3r,4e,6z,9z,16s,18r,32s,33s)-2,3-dihydroxy-14,29-diazapentacyclo[16.14.1.0¹,¹⁴.0¹⁶,³².0²⁹,³³]tritriaconta-4,6,9-triene-18-carbaldehyde

(1s,2s,3r,4e,6z,9z,16s,18r,32s,33s)-2,3-dihydroxy-14,29-diazapentacyclo[16.14.1.0¹,¹⁴.0¹⁶,³².0²⁹,³³]tritriaconta-4,6,9-triene-18-carbaldehyde

C32H50N2O3 (510.3821)


   

(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-methylbutanoate

(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-methylbutanoate

C35H58O2 (510.4437)


   

n-[2-(indol-1-yl)ethyl]tetracosanimidic acid

n-[2-(indol-1-yl)ethyl]tetracosanimidic acid

C34H58N2O (510.4549)


   

15-(5,5-dimethyl-6-methylideneoctan-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

15-(5,5-dimethyl-6-methylideneoctan-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

C35H58O2 (510.4437)


   

methyl (1r,2r,5s)-2-[(2r,3e)-5-{[(1r,4ar,4bs,7s,10ar)-7-ethenyl-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl]methoxy}-5-oxopent-3-en-2-yl]-5-methylcyclopentane-1-carboxylate

methyl (1r,2r,5s)-2-[(2r,3e)-5-{[(1r,4ar,4bs,7s,10ar)-7-ethenyl-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl]methoxy}-5-oxopent-3-en-2-yl]-5-methylcyclopentane-1-carboxylate

C33H50O4 (510.3709)


   

(3s,4ar,6ar,6br,8ar,12bs,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl pentanoate

(3s,4ar,6ar,6br,8ar,12bs,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl pentanoate

C35H58O2 (510.4437)


   

4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl 3-methylbutanoate

4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl 3-methylbutanoate

C35H58O2 (510.4437)


   

(1s,4r,9r,10s,13s,16r)-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl (1s,2s,4s)-4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

(1s,4r,9r,10s,13s,16r)-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl (1s,2s,4s)-4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

C33H50O4 (510.3709)


   

methyl 9-(acetyloxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-cyclopenta[a]chrysene-3a-carboxylate

methyl 9-(acetyloxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-cyclopenta[a]chrysene-3a-carboxylate

C33H50O4 (510.3709)


   

(2e,6r,7r,10e,14e,18s,19s,22e)-2,6,10,15,19,23-hexamethyltetracosa-2,10,14,22-tetraene-1,6,7,18,19,24-hexol

(2e,6r,7r,10e,14e,18s,19s,22e)-2,6,10,15,19,23-hexamethyltetracosa-2,10,14,22-tetraene-1,6,7,18,19,24-hexol

C30H54O6 (510.392)


   

4,4,6b,8a,11,12,12b,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,13,14-tetradecahydro-1h-picen-3-yl 3-methylbutanoate

4,4,6b,8a,11,12,12b,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,13,14-tetradecahydro-1h-picen-3-yl 3-methylbutanoate

C35H58O2 (510.4437)


   

(1s,4r,9r,10s,13s,16r)-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl (1r,2s,4s)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

(1s,4r,9r,10s,13s,16r)-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl (1r,2s,4s)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

C33H50O4 (510.3709)


   

(1s,3r,6s,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-15-[(2r)-6-methylheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl (2e)-2-methylbut-2-enoate

(1s,3r,6s,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-15-[(2r)-6-methylheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl (2e)-2-methylbut-2-enoate

C35H58O2 (510.4437)


   

(1r,4r,9r,10s,13r,15r)-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl (1s,2s,4s)-4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

(1r,4r,9r,10s,13r,15r)-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl (1s,2s,4s)-4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

C33H50O4 (510.3709)


   

(2r)-2-[(1r,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

(2r)-2-[(1r,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C33H50O4 (510.3709)


   

7-(dimethylamino)-1-{4-[1-(2-hydroxyethyl)-2,2-dimethylpyrrolidin-3-ylidene]butan-2-yl}-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-one

7-(dimethylamino)-1-{4-[1-(2-hydroxyethyl)-2,2-dimethylpyrrolidin-3-ylidene]butan-2-yl}-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-one

C33H54N2O2 (510.4185)


   

2-[6-(3-ethoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

2-[6-(3-ethoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

C33H50O4 (510.3709)


   

3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-oxobutanoate

3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-oxobutanoate

C34H54O3 (510.4073)


   

methyl (4as,6ar,6bs,8ar,10s,12as,14br)-10-(acetyloxy)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,14b-dodecahydropicene-4a-carboxylate

methyl (4as,6ar,6bs,8ar,10s,12as,14br)-10-(acetyloxy)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,14b-dodecahydropicene-4a-carboxylate

C33H50O4 (510.3709)


   

n-[2-(1h-indol-3-yl)ethyl]tetracosanimidic acid

n-[2-(1h-indol-3-yl)ethyl]tetracosanimidic acid

C34H58N2O (510.4549)


   

(2r)-2-[(3r,3ar,6s,7s,9br)-6-(3-ethoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

(2r)-2-[(3r,3ar,6s,7s,9br)-6-(3-ethoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

C33H50O4 (510.3709)


   

5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl 4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl 4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

C33H50O4 (510.3709)


   

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-oxobutanoate

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-oxobutanoate

C34H54O3 (510.4073)


   

7-(dimethylamino)-1-{4-[1-(2-hydroxyethyl)-2,2-dimethylpyrrolidin-3-ylidene]butan-2-yl}-9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-6-one

7-(dimethylamino)-1-{4-[1-(2-hydroxyethyl)-2,2-dimethylpyrrolidin-3-ylidene]butan-2-yl}-9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-6-one

C33H54N2O2 (510.4185)


   

(1r,7s,9as,11ar)-7-(dimethylamino)-1-[(2r)-4-[(3e)-1-(2-hydroxyethyl)-2,2-dimethylpyrrolidin-3-ylidene]butan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-6-one

(1r,7s,9as,11ar)-7-(dimethylamino)-1-[(2r)-4-[(3e)-1-(2-hydroxyethyl)-2,2-dimethylpyrrolidin-3-ylidene]butan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-6-one

C33H54N2O2 (510.4185)


   

(6r,17e,29e,31r)-1,6,31-trihydroxytritriaconta-17,29-dien-2,4,32-triyn-16-one

(6r,17e,29e,31r)-1,6,31-trihydroxytritriaconta-17,29-dien-2,4,32-triyn-16-one

C33H50O4 (510.3709)


   

4,5,9,9,12,12,16,22,23-nonamethyl-11,13,27-trioxaheptacyclo[20.3.2.0¹,²¹.0⁴,²⁰.0⁵,¹⁷.0⁸,¹⁶.0¹⁰,¹⁴]heptacos-20-en-26-one

4,5,9,9,12,12,16,22,23-nonamethyl-11,13,27-trioxaheptacyclo[20.3.2.0¹,²¹.0⁴,²⁰.0⁵,¹⁷.0⁸,¹⁶.0¹⁰,¹⁴]heptacos-20-en-26-one

C33H50O4 (510.3709)


   

2-[7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

2-[7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C33H50O4 (510.3709)


   

(2e,10e,14e,22e)-2,6,10,15,19,23-hexamethyltetracosa-2,10,14,22-tetraene-1,6,7,18,19,24-hexol

(2e,10e,14e,22e)-2,6,10,15,19,23-hexamethyltetracosa-2,10,14,22-tetraene-1,6,7,18,19,24-hexol

C30H54O6 (510.392)


   

5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl 4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl 4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

C33H50O4 (510.3709)


   

(2s)-2-[(3s,3as,6r,7r,9bs)-6-(3-ethoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

(2s)-2-[(3s,3as,6r,7r,9bs)-6-(3-ethoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

C33H50O4 (510.3709)


   

3-[(7e)-10-(pyridin-3-yl)dec-7-en-1-yl]-1-[(8e)-10-(pyridin-3-yl)dec-8-en-1-yl]pyridin-1-ium

3-[(7e)-10-(pyridin-3-yl)dec-7-en-1-yl]-1-[(8e)-10-(pyridin-3-yl)dec-8-en-1-yl]pyridin-1-ium

[C35H48N3]+ (510.3848)


   

1,12-bis[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9-dimethyldodeca-4,8-diene-1,12-diol

1,12-bis[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9-dimethyldodeca-4,8-diene-1,12-diol

C30H54O6 (510.392)


   

(17e,29e)-1,6,31-trihydroxytritriaconta-17,29-dien-2,4,32-triyn-16-one

(17e,29e)-1,6,31-trihydroxytritriaconta-17,29-dien-2,4,32-triyn-16-one

C33H50O4 (510.3709)


   

methyl (1r,3as,5as,5br,7ar,9s,11ar,11br,13bs)-9-(acetyloxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-cyclopenta[a]chrysene-3a-carboxylate

methyl (1r,3as,5as,5br,7ar,9s,11ar,11br,13bs)-9-(acetyloxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-cyclopenta[a]chrysene-3a-carboxylate

C33H50O4 (510.3709)


   

(3s,4as,6bs,8ar,11r,12s,12ar,12bs,14bs)-4,4,6b,8a,11,12,12b,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,13,14-tetradecahydro-1h-picen-3-yl 3-methylbutanoate

(3s,4as,6bs,8ar,11r,12s,12ar,12bs,14bs)-4,4,6b,8a,11,12,12b,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,13,14-tetradecahydro-1h-picen-3-yl 3-methylbutanoate

C35H58O2 (510.4437)


   

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-methylbutanoate

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-methylbutanoate

C35H58O2 (510.4437)


   

(3s,4ar,6ar,6br,8ar,12s,12ar,12br,14ar,14br)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl 3-methylbutanoate

(3s,4ar,6ar,6br,8ar,12s,12ar,12br,14ar,14br)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl 3-methylbutanoate

C35H58O2 (510.4437)


   

3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-methylbutanoate

3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-methylbutanoate

C35H58O2 (510.4437)


   

(3r,6as,6br,8ar,12ar,12bs,14ar,14bs)-4,4,6b,8a,11,11,12b,14a-octamethyl-1,2,3,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydropicen-3-yl (2r)-2-methylbutanoate

(3r,6as,6br,8ar,12ar,12bs,14ar,14bs)-4,4,6b,8a,11,11,12b,14a-octamethyl-1,2,3,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydropicen-3-yl (2r)-2-methylbutanoate

C35H58O2 (510.4437)


   

(1r,4e,8e,12r)-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-12-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9-dimethyldodeca-4,8-diene-1,12-diol

(1r,4e,8e,12r)-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-12-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9-dimethyldodeca-4,8-diene-1,12-diol

C30H54O6 (510.392)


   

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl pentanoate

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl pentanoate

C35H58O2 (510.4437)


   

(1s,3r,6s,8s,11r,12s,15r,16r)-15-[(2r)-5,5-dimethyl-6-methylideneoctan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

(1s,3r,6s,8s,11r,12s,15r,16r)-15-[(2r)-5,5-dimethyl-6-methylideneoctan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

C35H58O2 (510.4437)


   

methyl 2-{5-[(7-ethenyl-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl)methoxy]-5-oxopent-3-en-2-yl}-5-methylcyclopentane-1-carboxylate

methyl 2-{5-[(7-ethenyl-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl)methoxy]-5-oxopent-3-en-2-yl}-5-methylcyclopentane-1-carboxylate

C33H50O4 (510.3709)


   

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-methylbutanoate

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-methylbutanoate

C35H58O2 (510.4437)


   

(1r,7s,9ar,11ar)-7-(dimethylamino)-1-[(2r)-4-[(3e)-1-(2-hydroxyethyl)-2,2-dimethylpyrrolidin-3-ylidene]butan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-one

(1r,7s,9ar,11ar)-7-(dimethylamino)-1-[(2r)-4-[(3e)-1-(2-hydroxyethyl)-2,2-dimethylpyrrolidin-3-ylidene]butan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-one

C33H54N2O2 (510.4185)


   

(1s,3r,6s,12s,15r,16r)-15-[(2r,4s)-4-ethyl-6-methyl-5-methylideneheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

(1s,3r,6s,12s,15r,16r)-15-[(2r,4s)-4-ethyl-6-methyl-5-methylideneheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

C35H58O2 (510.4437)


   

(1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r)-5,5-dimethyl-6-methylideneoctan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

(1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r)-5,5-dimethyl-6-methylideneoctan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

C35H58O2 (510.4437)


   

15-(4-ethyl-6-methyl-5-methylideneheptan-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

15-(4-ethyl-6-methyl-5-methylideneheptan-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

C35H58O2 (510.4437)


   

5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl 1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl 1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl propanedioate

C33H50O4 (510.3709)


   

(2e,6r,7s,10e,14e,18r,19s,22e)-2,6,10,15,19,23-hexamethyltetracosa-2,10,14,22-tetraene-1,6,7,18,19,24-hexol

(2e,6r,7s,10e,14e,18r,19s,22e)-2,6,10,15,19,23-hexamethyltetracosa-2,10,14,22-tetraene-1,6,7,18,19,24-hexol

C30H54O6 (510.392)


   

(1r,4e,8e,12r)-1,12-bis[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9-dimethyldodeca-4,8-diene-1,12-diol

(1r,4e,8e,12r)-1,12-bis[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9-dimethyldodeca-4,8-diene-1,12-diol

C30H54O6 (510.392)


   

4,4,6b,8a,11,11,12b,14a-octamethyl-1,2,3,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydropicen-3-yl 2-methylbutanoate

4,4,6b,8a,11,11,12b,14a-octamethyl-1,2,3,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydropicen-3-yl 2-methylbutanoate

C35H58O2 (510.4437)


   

(1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r,4s)-4-ethyl-6-methyl-5-methylideneheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

(1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r,4s)-4-ethyl-6-methyl-5-methylideneheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

C35H58O2 (510.4437)


   

7-(dimethylamino)-1-{4-[(3z)-1-(2-hydroxyethyl)-2,2-dimethylpyrrolidin-3-ylidene]butan-2-yl}-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-one

7-(dimethylamino)-1-{4-[(3z)-1-(2-hydroxyethyl)-2,2-dimethylpyrrolidin-3-ylidene]butan-2-yl}-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-one

C33H54N2O2 (510.4185)


   

(1s,4s,5r,8r,10r,14s,16r,17r,22s,23r)-4,5,9,9,12,12,16,22,23-nonamethyl-11,13,27-trioxaheptacyclo[20.3.2.0¹,²¹.0⁴,²⁰.0⁵,¹⁷.0⁸,¹⁶.0¹⁰,¹⁴]heptacos-20-en-26-one

(1s,4s,5r,8r,10r,14s,16r,17r,22s,23r)-4,5,9,9,12,12,16,22,23-nonamethyl-11,13,27-trioxaheptacyclo[20.3.2.0¹,²¹.0⁴,²⁰.0⁵,¹⁷.0⁸,¹⁶.0¹⁰,¹⁴]heptacos-20-en-26-one

C33H50O4 (510.3709)